This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

27 Jul 2011

Amylin Reports Second Quarter Financial Results

The San Diego drug company said it lost $31.4 million, or 22 cents a share, better than the $44.2 million, or 31 cent a share, it lost a year earlier.

US drugmaker Amylin Pharmaceuticals reported yesterday its financial results for the quarter ended June 30, 2011.


The company's total revenue was $158.1 million for the quarter ended June 30, 2011, which included net product sales of $154.8 million.


Non-GAAP operating loss was $1.7 million, compared to $7.4 million for the same period in 2010.


GAAP net loss was $31.4 million, or $0.22 per share, compared to $44.2 million, or $0.31 per share, for the same period in 2010.


The Company held cash, cash equivalents, short-term investments and restricted cash

Related News